Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Valproic Acid + Cisplatin + Cetuximab in Head and Neck Cancer
NCT02624128Phase 2Unknown
- Sponsor
- National Cancer Institute
- Start
- Feb 2015
- Primary completion
- Apr 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of valproic acid in squamous cell carcinoma of the head and neck (HNSCC), sponsored by National Cancer Institute. Status: unknown.
02
Drugs
valproic acid
03
Conditions
squamous cell carcinoma of the head and neck (HNSCC)
Beyond the preview
Go deeper on NCT02624128.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02624128.